221 related articles for article (PubMed ID: 17987782)
1. Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model.
Ohno T; Hirano S; Kanemaru S; Yamashita M; Umeda H; Suehiro A; Tamura Y; Nakamura T; Ito J; Tabata Y
Ann Otol Rhinol Laryngol; 2007 Oct; 116(10):762-9. PubMed ID: 17987782
[TBL] [Abstract][Full Text] [Related]
2. Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel.
Kishimoto Y; Hirano S; Kitani Y; Suehiro A; Umeda H; Tateya I; Kanemaru S; Tabata Y; Ito J
Laryngoscope; 2010 Jan; 120(1):108-13. PubMed ID: 19877197
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery system of basic fibroblast growth factor using gelatin hydrogel for restoration of acute vocal fold scar.
Kobayashi T; Mizuta M; Hiwatashi N; Kishimoto Y; Nakamura T; Kanemaru SI; Hirano S
Auris Nasus Larynx; 2017 Feb; 44(1):86-92. PubMed ID: 27126068
[TBL] [Abstract][Full Text] [Related]
4. Growth factor therapy for vocal fold scarring in a canine model.
Hirano S; Bless DM; Nagai H; Rousseau B; Welham NV; Montequin DW; Ford CN
Ann Otol Rhinol Laryngol; 2004 Oct; 113(10):777-85. PubMed ID: 15535139
[TBL] [Abstract][Full Text] [Related]
5. Restoration of scarred vocal folds using 5 amino acid-deleted type hepatocyte growth factor.
Mizuta M; Hirano S; Ohno S; Kanemaru S; Nakamura T; Ito J
Laryngoscope; 2014 Mar; 124(3):E81-6. PubMed ID: 24115162
[TBL] [Abstract][Full Text] [Related]
6. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model.
Hirano S; Bless DM; Rousseau B; Welham N; Montequin D; Chan RW; Ford CN
Laryngoscope; 2004 Mar; 114(3):548-56. PubMed ID: 15091233
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor β3 for the prevention of vocal fold scarring.
Ohno S; Hirano S; Kanemaru S; Kitani Y; Kojima T; Ishikawa S; Mizuta M; Tateya I; Nakamura T; Ito J
Laryngoscope; 2012 Mar; 122(3):583-9. PubMed ID: 22252900
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of a novel collagen-gelatin scaffold with basic fibroblast growth factor for the treatment of vocal fold scar.
Hiwatashi N; Hirano S; Mizuta M; Kobayashi T; Kawai Y; Kanemaru SI; Nakamura T; Ito J; Kawai K; Suzuki S
J Tissue Eng Regen Med; 2017 May; 11(5):1598-1609. PubMed ID: 26119035
[TBL] [Abstract][Full Text] [Related]
9. Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar.
Krishna P; Rosen CA; Branski RC; Wells A; Hebda PA
Otolaryngol Head Neck Surg; 2006 Dec; 135(6):937-45. PubMed ID: 17141088
[TBL] [Abstract][Full Text] [Related]
10. Implantation of an atelocollagen sponge with autologous bone marrow-derived mesenchymal stromal cells for treatment of vocal fold scarring in a canine model.
Ohno S; Hirano S; Kanemaru S; Kitani Y; Kojima T; Tateya I; Nakamura T; Ito J
Ann Otol Rhinol Laryngol; 2011 Jun; 120(6):401-8. PubMed ID: 21774449
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin and adhesion molecules on canine scarred vocal folds.
Hirano S; Bless DM; Rousseau B; Welham N; Scheidt T; Ford CN
Laryngoscope; 2003 Jun; 113(6):966-72. PubMed ID: 12782806
[TBL] [Abstract][Full Text] [Related]
12. Effects of hepatocyte growth factor injection and reinjection on healing in the rabbit vocal fold.
Dias Garcia RI; Tsuji DH; Imamura R; Mauad T; Ferraz da Silva LF
J Voice; 2012 Sep; 26(5):667.e7-12. PubMed ID: 22296997
[TBL] [Abstract][Full Text] [Related]
13. Characterization of vocal fold scarring in a canine model.
Rousseau B; Hirano S; Scheidt TD; Welham NV; Thibeault SL; Chan RW; Bless DM
Laryngoscope; 2003 Apr; 113(4):620-7. PubMed ID: 12671417
[TBL] [Abstract][Full Text] [Related]
14. Functional and Histological Evaluation following Canine Vocal Fold Reconstruction Using Composite Thyroid Ala Perichondrium Flaps.
Hoffman MR; Glab R; Gunderson M; Maytag AL; Yang DT; Jiang JJ; Dailey SH
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):79-87. PubMed ID: 25883099
[TBL] [Abstract][Full Text] [Related]
15. Characterization of chronic vocal fold scarring in a rabbit model.
Rousseau B; Hirano S; Chan RW; Welham NV; Thibeault SL; Ford CN; Bless DM
J Voice; 2004 Mar; 18(1):116-24. PubMed ID: 15070231
[TBL] [Abstract][Full Text] [Related]
16. Histologic characterization of human scarred vocal folds.
Hirano S; Minamiguchi S; Yamashita M; Ohno T; Kanemaru S; Kitamura M
J Voice; 2009 Jul; 23(4):399-407. PubMed ID: 18395421
[TBL] [Abstract][Full Text] [Related]
17. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts.
Hirano S; Bless D; Heisey D; Ford C
Laryngoscope; 2003 Jan; 113(1):144-8. PubMed ID: 12514399
[TBL] [Abstract][Full Text] [Related]
18. Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection.
Hertegård S; Cedervall J; Svensson B; Forsberg K; Maurer FH; Vidovska D; Olivius P; Ahrlund-Richter L; Le Blanc K
Laryngoscope; 2006 Jul; 116(7):1248-54. PubMed ID: 16826069
[TBL] [Abstract][Full Text] [Related]
19. Controlled Release of Hepatocyte Growth Factor from MPEG-b-(PCL-ran-PLLA) Diblock Copolymer for Improved Vocal Fold Regeneration.
Choi JW; Kim YS; Park JK; Song EH; Park JH; Kim MS; Shin YS; Kim CH
Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27648819
[TBL] [Abstract][Full Text] [Related]
20. Functional remodeling after vocal fold injury by small intestinal submucosa gel containing hepatocyte growth factor.
Choi JS; Lee S; Kim DY; Kim YM; Kim MS; Lim JY
Biomaterials; 2015 Feb; 40():98-106. PubMed ID: 25433606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
